Abstract
The purpose of this study was to estimate the prevalence of tuberculosis among patients undergoing treatment at the ERCC medical centre in Alushi from January 2017 to July 2021. A total of 3029 TB presumptive patients were included in the current investigation. The overall TB prevalence was 43.57%. There were 993 (64.90%) males, 10.1% of whom were rifampicin resistant, and 537 (35.09%) females, 34.8% of whom were rifampicin resistant. The highest prevalence is recorded in all age groups, was seen in the age bracket 21-30 with a total of 350 (26.51%) and 327 (24.77%) in the age range 31-40. Findings revealed that having a history of TB medication and being female were both associated with the development of rifampicin-resistant Tuberculosis and patients aged 21 to 40 were more likely than others to be infected with tuberculosis and develop rifampicin-resistant tuberculosis. Because of the high prevalence, immediate action is essential to encourage early identification and the completion of DR-TB medication in order to prevent the disease from spreading in the community, as well as continuous community health education about tuberculosis and the risk of drug resistance
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
